Rogco LP’s Pfizer PFE Stock Holding History

Rogco LP’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$516K	Buy	18,376 +125	+0.7%	+$3.33K	0.17%	84
2025 Q4	$454K	Sell	18,251 -143	-0.8%	-$3.61K	0.15%	88
2025 Q3	$469K	Sell	18,394 -1,421	-7%	-$35.1K	0.16%	84
2025 Q2	$480K	Buy	19,815 +539	+3%	+$12.6K	0.18%	84
2025 Q1	$488K	Buy	19,276 +2,688	+16%	+$70.3K	0.2%	78
2024 Q4	$440K	Sell	16,588 -2,241	-12%	-$60.8K	0.18%	82
2024 Q3	$545K	Sell	18,829 -965	-5%	-$28.1K	0.21%	76
2024 Q2	$554K	Sell	19,794 -290	-1%	-$7.98K	0.23%	71
2024 Q1	$557K	Sell	20,084 -1,989	-9%	-$55.2K	0.23%	71
2023 Q4	$635K	Sell	22,073 -30	-0.1%	-$907	0.28%	59
2023 Q3	$733K	Buy	+22,103	New	+$782K	0.36%	46

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Rogco LP's PFE Position: Q1 2026 in Review

Rogco LP increased its Pfizer (PFE) stake by 0.68% in Q1 2026, buying an estimated $3.33K and bringing the position to 18,376 shares worth $516K. The position accounts for 0.17% of the portfolio, ranked #84.

Rogco LP first reported a position in PFE in Q3 2023 and has held it in 11 quarters since. The position peaked at $733K in Q3 2023. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Rogco LP held 18,376 shares of Pfizer worth $516K as of Q1 2026.
Rogco LP bought 125 Pfizer shares in Q1 2026, an estimated $3.33K.
Pfizer made up 0.17% of Rogco LP's portfolio in Q1 2026, its #84 holding.
Rogco LP first reported a position in Pfizer in Q3 2023 and has held it in 11 quarters since.
Rogco LP's Pfizer position peaked at $733K in Q3 2023.
2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Rogco LP's 13F filing for Q1 2026, filed 5 May 2026.